FY-EM4665 Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) ELISA Kit

NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) Basic information

The N-terminal prohormone of brain natriuretic peptide (NT-proBNP or BNPT) is a prohormone with a 76 amino acid N-terminal inactive protein that is cleaved from the molecule to release brain natriuretic peptide.

Both BNP and NT-proBNP levels in the blood are used for screening, diagnosis of acute congestive heart failure (CHF) and may be useful to establish prognosis in heart failure, as both markers are typically higher in patients with worse outcome. The plasma concentrations of both BNP and NT-proBNP are also typically increased in patients with asymptomatic or symptomatic left ventricular dysfunction and is associated with coronary artery disease and myocardial ischemia.

Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) ELISA Kit test method

Feiyue’s Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) is an ELISA reagent for detection of NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) in Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

This kit uses sandwich ELISA to detect the concentration of Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide). Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide)-specific monoclonal antibody has been pre-coated in the wells of the supplied microplate. Standards samples and controls are added to interact with the immobilized antibody. A sandwich complex is formed by additional anti-Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) antibody with HRP-Streptavidin. TMB solution is added to react with the sandwich for ming optical signal measured by microplate reader. The concentration of Mouse NT-proBNP(N-terminal pro-Brain Natriuretic Peptide) in the sample can be calculated by comparing the absorbance of the sample with the standard curve.

Reference:

 1.Bhalla V, Willis S, Maisel AS (2004). "B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure". Congestive Heart Failure. 10 (1 Suppl 1): 3–27. doi:10.1111/j.1527-5299.2004.03310.x. PMID 14872150.

 2.Atisha D, Bhalla MA, Morrison LK, Felicio L, Clopton P, Gardetto N, Kazanegra R, Chiu A, Maisel AS (September 2004). "A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction". American Heart Journal. 148 (3): 518–23. doi:10.1016/j.ahj.2004.03.014. PMID 15389242.

 3.Nakamura T, Sakamoto K, Yamano T, Kikkawa M, Zen K, Hikosaka T, Kubota T, Azuma A, Nishimura T (May 2002). "Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy". Journal of the American College of Cardiology. 39 (10): 1657–63. doi:10.1016/s0735-1097(02)01813-2. PMID 12020494.

 4.Talwar S, Squire IB, Downie PF, Davies JE, Ng LL (October 2000). "Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina". Heart. 84 (4): 421–4. doi:10.1136/heart.84.4.421. PMC 1729429. PMID 10995414.